Showing results (31-40 of 58) with videos related to
Sort By:
Pageof 6
Hormone Research in Paediatrics|December 10, 2024
International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Diabetes Technologies - Insulin DeliveryTorben Biester, Cari Berget, Charlotte Boughton, et al.Diabetes Technology & Therapeutics|July 18, 2022
Impact of Temporary Glycemic Target Use in the Hybrid and Advanced Hybrid Closed-Loop SystemsKlemen Dovc, Tadej Battelino, Roy W Beck, et al.Diabetes Technology & Therapeutics|July 5, 2023
A Comparison of Faster Insulin Aspart with Standard Insulin Aspart Using Hybrid Automated Insulin Delivery System in Active Children and Adolescents with Type 1 Diabetes: A Randomized Double-Blind Crossover TrialKlemen Dovc, Simon Bergford, Elke Fröhlich-Reiterer, et al.Diabetes, Obesity & Metabolism|November 20, 2020
Add-on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The DAPADream studyTorben Biester, Ido Muller, Thekla von dem Berge, et al.JAMA Network Open|February 22, 2023
Association of Achieving Time in Range Clinical Targets With Treatment Modality Among Youths With Type 1 DiabetesKlemen Dovc, Stefanie Lanzinger, Roque Cardona-Hernandez, et al.Hormone Research in Paediatrics|December 12, 2024
Regional Deprivation and Diabetic Ketoacidosis at Type 1 Diabetes Diagnosis in Children and Adolescents: International Comparison among 6 CountriesG Todd Alonso, Christina Reinauer, Georgina M Williams, et al.Diabetes, Obesity & Metabolism|November 28, 2018
DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at homeTorben Biester, Judith Nir, Kerstin Remus, et al.Diabetes Technology & Therapeutics|June 4, 2021
A Worldwide Perspective on COVID-19 and Diabetes Management in 22,820 Children from the SWEET Project: Diabetic Ketoacidosis Rates Increase and Glycemic Control Is MaintainedThomas Danne, Stefanie Lanzinger, Martin de Bock, et al.Hormone Research in Paediatrics|December 19, 2024
International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Glycemic TargetsMartin de Bock, Juliana Chizo Agwu, Matt Deabreu, et al.Diabetes Research and Clinical Practice|June 29, 2023
Diabetes care practices and outcomes in 40.000 children and adolescents with type 1 diabetes from the SWEET registry during the COVID-19 pandemicAgata Chobot, Stefanie Lanzinger, Hessa Alkandari, et al.Pageof 6